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Using hearts from mice overexpressing integrin linked kinase (ILK)
behind the cardiac speciﬁc promoter αMHC, we have performed
immunoprecipitation and mass spectrometry to identify novel ILK
protein:protein interactions that regulate cardiomyocyte activity
and calcium ﬂux. Integrin linked kinase complexes were captured
from mouse heart lysates using a commercial antibody, with
subsequent liquid chromatography tandem mass spectral analysis.
Interacting partners were identiﬁed using the MASCOT server, and
important interactions veriﬁed using reverse immunoprecipitation
and mass spectrometry. All ILK interacting proteins were identiﬁed
in a non-biased manner, and are stored in the ProteomeXchange
Consortium via the PRIDE partner repository (reference ID PRIDE:
PXD001053). The functional role of identiﬁed ILK interactions in
cardiomyocyte function and arrhythmia were subsequently con-
ﬁrmed in human iPSC-cardiomyocytes.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
aynes).
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ject areaMolecular Cardiologyype of data Mass Spectrometry Table
ow data was
acquiredOn-line liquid chromatography-tandem mass spectrometry set-up using an
Agilent 1100 Capillary LC system ﬁtted to a LTQ ion trap mass spectrometer. A
C18 pre-column (100 mm i.d. 5.0 cm length) and a mLC analytical column (75
mm 10 cm) that also served as a mESI emitter were used for the separation of
the digested proteins.ata format Raw
xperimental
factorsMouse heart lysates prepared using standard RIPA bufferxperimental
featuresImmunoprecipitation of fresh mouse heart lysates, captured via Protein-A beads
before injection onto mass spectrometry.ata source
locationToronto, Canadaata accessibility Data is within this article and at http://www.proteomexchange.org/, refer-
ence ID PRIDE: PXD001053, http://proteomecentral.proteomexchange.org/
cgi/GetDataset?ID¼PXD001053Value of the data
 Control, benchmark data for mouse heart immunoprecipitation.
 Benchmark mass spectrometry data for protein analysis under cardiac speciﬁc promoters.
 Comparison data set for heart failure and proteins involved in cardiac function.
 Correlation of mouse heart protein analysis and human iPSC-cardiomyocyte interactions.
 Use of high resolution mass spectrometry on a biological sample with disease phenotype.
 Novel cardiac interactions of ILK, a key protein in cardiac force transduction.
 Only in vivo data available for ILK-expression model, with documented in vivo cardiac phenotype.1. Data
The dataset represents proteins that were identiﬁed to interact with integrin-linked kinase after
immunoprecipitation from a model of cardiac-speciﬁc expression, with identiﬁcation via mass
spectrometry. The RAW data ﬁles generated from LC-MS-MS analysis of ILK immunoprecipitations
have been provided, and are deposited in the ProteomeExchange (reference ID PRIDE: PXD001053).2. Experimental design, materials and methods
Hearts from ILK-transgenic mice (with cardiac-speciﬁc over-expression of ILK wild-type (WT))
were harvested and lysates prepared in ice-cold RIPA buffer [1]. Tissue extracts were prepared with
RIPA lysis buffer (150 mM NaCl, 1% Nonidet P40, 05% deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0 and
1 mM phenylmethylsulphonyl ﬂuoride) supplemented with 1 complete protease inhibitor cocktail
(EDTA-free) (Roche Diagnostics GmbH, Penzberg, Germany). The samples were centrifuged, and the
resulting protein lysate (2 mg) were incubated overnight at 4 °C with either 2 μg of anti-ILK rabbit
antibody (catalogue number: 3856, Cell Signaling Technology) or control rabbit IgG (catalogue
number: 011-000-003, Jackson ImmunoResearch Lab. Inc.). The samples were than incubated for 2 h
at 4 °C with protein A agarose beads (catalogue number: sc-2001, Santa Cruz Biotechnology) and the
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with 1protein sample buffer, boiled and resolved on a 6-18% acrylamide gradient SDS gel. After
Coomassie Blue staining, the extra bands on the IP lane contrasting to the control lane were excised
from the gel and tryptically digested for MS/MS analysis. Brieﬂy, excised gel spots were destained and
washed with ACN (50%) and AMBIC (100 mM), followed by drying in a vacuum centrifuge (UNIVAPO,
uniEquip, Matinsried, Germany). The dried gel pieces were digested with trypsin containing digestion
buffer (0.1 μg/μL trypsin, 1 M CaCl2, 1 M AMBIC (pH 7.4)) for 45 min on ice. The excess amount of
trypsin solution was replaced by the same volume of 100 mM of AMBIC without trypsin and incu-
bated overnight at 37 °C. The peptides were extracted with increasing concentrations of ACN and TFA
and dried by vacuum centrifugation before being analyzed by mass spectrometry.
Mass spectrometry was performed using an on-line liquid chromatography-tandem mass spec-
trometry system. An Agilent 1100 Capillary LC system (Palo Alto, CA, USA) ﬁtted to a LTQ ion trap mass
spectrometer (Thermo Electron, San Jose, CA, USA) was used for analysis. A C18 pre-column (100 mm
i.d5.0 cm length) and a μLC analytical column (75 mm10 cm), that also served as a μESI emitter,
were used for the separation of the digested proteins. The mass spectrometer was operated in data-
dependent mode, automatically cycling through acquisition of a full-scan mass spectrum and three
MS/MS spectra recorded sequentially. A dynamic exclusion list time of 1.5 min was used. For the
reverse phase chromatography, an 80-min gradient elution from water to acetonitrile, each con-
taining 0.1% FA and 0.02% TFA, was performed at a ﬂow of 200 nl/min. All MS/MS spectra were
searched against the NCBInr protein database using MASCOT Server (v2.2; Matrix Science) [2]. The
search results were analysed using the Scaffold software (Proteome Software) [3]. The RAW data ﬁles
are archived with the ProteomeExchange (address above). Scaffold identiﬁed 74 proteins, without a
cutoff for the minimum number of spectral counts (range 18 to 1 spectral counts), although two of the
proteins identiﬁed were likely the antibody used for the immunoprecipitation. To reduce the chance
of identifying a non-speciﬁc interaction (i.e. “sticky” protein), the results were culled using the
CRAPome database [4]. SERCA-2a possessed the largest number of spectral counts, and was fully
investigated for biological relevance [5]. Other identiﬁed proteins had been investigated as ILK
binding partners, including Hsp70, and published [6].Appendix A. Supplementary material
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2016.03.056.References
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